Yes, it’s a bit of a trap for Bryan Johnson, he has to keep pushing the envelope to newer and less validated interventions to keep getting attention… which drives the Blueprint business. He’s done most of the low hanging fruit…
4 Likes
Exactly that 
methoxetamine… that should be next
